A Randomized Clinical Trial of Anti-IL-6 Antibody Clazakizumab in Late Antibody-Mediated Kidney Transplant Rejection. Doberer K, Duerr M, Halloran PF, Eskandary F, et al. J Am Soc Nephrol 2020 Dec 18. pii: ASN.2020071106. doi: 10.1681/ASN.2020071106.

Read + Share

Amedeo Smart

Independent Medical Education

Doberer K, Duerr M, Halloran PF, Eskandary F, et al. A Randomized Clinical Trial of Anti-IL-6 Antibody Clazakizumab in Late Antibody-Mediated Kidney Transplant Rejection. J Am Soc Nephrol 2020 Dec 18. pii: ASN.2020071106. doi: 10.1681/ASN.2020071106.
PMID: 33443079